"Adaptative endovascular strategy to the CloT MRI in large intracranial vessel occlusion" (VECTOR): Study protocol of a randomized control trial.


Journal

Journal of neuroradiology = Journal de neuroradiologie
ISSN: 0150-9861
Titre abrégé: J Neuroradiol
Pays: France
ID NLM: 7705086

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 01 09 2019
revised: 18 10 2019
accepted: 04 11 2019
pubmed: 15 11 2019
medline: 8 5 2021
entrez: 15 11 2019
Statut: ppublish

Résumé

A correlation between the susceptibility vessel sign (SVS) and red thrombi has been identified in MRI. We hypothesized that the Embotrap allow better retrieving of SVS+ thrombi. The AdaptatiVe Endovascular strategy to the CloT MRI in large intracranial vessel Occlusion (VECTOR) trial is a multicenter, prospective and randomized study designed to compare a first-line strategy combining Embotrap added to contact aspiration (CA) versus CA alone in patients with SVS+ occlusions.

Identifiants

pubmed: 31726072
pii: S0150-9861(19)30464-X
doi: 10.1016/j.neurad.2019.11.001
pii:
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

382-385

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Kevin Janot (K)

Department of Neuroradiology, University Hospital of Tours, 2, boulevard Tonnellé, 37000 Tours, France. Electronic address: kevin.janot@hotmail.com.

François Zhu (F)

University Hospital of Nancy, France.

Basile Kerleroux (B)

Department of Neuroradiology, University Hospital of Tours, 2, boulevard Tonnellé, 37000 Tours, France.

Grégoire Boulouis (G)

Saint-Anne Hospital, Paris, France.

Eimad Shotar (E)

La Pitie-Salpetrière Hospital, Paris, France.

Kevin Premat (K)

La Pitie-Salpetrière Hospital, Paris, France.

François Eugene (F)

University Hospital of Rennes, Rennes, France.

Cyril Dargazanli (C)

University Hospital of Montpellier, Montpellier, France.

Vanessa Chalumeau (V)

Bicêtre Hospital, Le Kremlin-Bicêtre, France.

Vincent L'Allinec (V)

University Hospital of Angers, Angers, France.

Wagih Benhassen (W)

Saint-Anne Hospital, Paris, France.

Gaultier Marnat (G)

University Hospital of Bordeaux, Bordeaux, France.

Anthony Lebras (A)

Regional Hospital of Vannes, Vannes, France.

Lili Detraz (L)

University Hospital of Nantes, Nantes, France.

Julien Ognard (J)

University Hospital of Brest, Brest, France.

Thomas Personnic (T)

University Hospital of Lille, Lille, France.

Cyril Chivot (C)

University Hospital of Amiens, Amiens, France.

Matteo Cappucci (M)

University Hospital of Lyon, Lyon, France.

Géraud Forestier (G)

University Hospital of Limoges, Limoges, France.

Sébastien Soize (S)

University Hospital of Reims, Reims, France.

Frédéric Bourdain (F)

Regional Hospital of Bayonne, Bayonne, France.

Arthuro Consoli (A)

Foch Hospital, Suresnes, France.

Julien Labreuche (J)

Department of Biostatistics, University Hospital of Lille, Lille, France.

Hubert Desal (H)

University Hospital of Nantes, Nantes, France.

Bertrand Lapergue (B)

Foch Hospital, Suresnes, France.

Aymeric Rouchaud (A)

University Hospital of Limoges, Limoges, France.

Romain Bourcier (R)

University Hospital of Nantes, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH